Case of ossifying epithelioid hemangioendothelioma on the forearm.

J Dermatol

Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Published: August 2015

Download full-text PDF

Source
http://dx.doi.org/10.1111/1346-8138.12915DOI Listing

Publication Analysis

Top Keywords

case ossifying
4
ossifying epithelioid
4
epithelioid hemangioendothelioma
4
hemangioendothelioma forearm
4
case
1
epithelioid
1
hemangioendothelioma
1
forearm
1

Similar Publications

[Comparison of effectiveness between two surgical methods for humeral lateral condyle fractures in children].

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi

January 2025

Department of Orthopedics, Anhui Provincial Children's Hospital, Anhui Medical University Children's Medical Center, Hefei Anhui, 230051, P. R. China.

Objective: To compare the effectiveness of ultrasound-guided closed reduction with Kirschner wire fixation and open reduction with Kirschner wire fixation in the treatment of humeral lateral condyle fracture (HLCF) in children.

Methods: A clinical data of 53 children with HLCF admitted between May 2020 and April 2023 and met selective criteria was retrospectively analyzed. Of these, 25 cases were managed with closed reduction and Kirschner wire fixation under ultrasound guidance (closed group), while 28 cases underwent open reduction and Kirschner wire fixation (open group).

View Article and Find Full Text PDF

Biting off more than you can chew: a rare case of hyperparathyroidism jaw tumour syndrome.

Oxf Med Case Reports

January 2025

Consultant Nephrologist-Department of Nephrology and Transplantation, Fiona Stanley Hospital, Perth, WA, Australia.

Hyperparathyroidism Jaw Tumour Syndrome (HPT-JT) is a rare autosomal dominant disorder within the familial hyperparathyroidism group. Individuals with the disorder carry a gene mutation that predisposes them to early-onset primary hyperparathyroidism, ossifying jaw tumours, renal cystic disease, uterine tumours and parathyroid carcinomas. We present a case of a 41-year-old man referred to nephrology clinic with haemoproteinuria who was noted to have the constellation of renal cystic disease, personal and family history of hyperparathyroidism and recent jaw tumour excision.

View Article and Find Full Text PDF

Eighteen months after the resection and micro-vascular reconstruction of central ossifying fibroma of the right mandible in a 54-year-old male patient, there occur two synchronous neoplasms, basal cell adenoma (BSA) and oral squamous cell carcinoma (OSCC). Two years after reconstructive surgery, the patient reported a second primary OSCC on the left retromolar mucosa. This case reports two morphologically diverse benign neoplasms preceding metachronous OSCC in one individual.

View Article and Find Full Text PDF

Jaffe-Campanacci syndrome (JCS) is a rare disorder characterized by multiple non-ossifying fibromas (NOFs), café-au-lait spots, and other features such as mental retardation and cryptorchidism. It is often clinically and genetically similar to neurofibromatosis type 1 (NF1), complicating diagnosis. This report presents a 17-year-old male with right knee pain, café-au-lait spots, and axillary freckling.

View Article and Find Full Text PDF

Ossifying fibromyxoid tumours: A case series.

Eur J Cancer

January 2025

Department of Medical Oncology, The Royal Marsden NHS Foundation Trust, London, UK; Institute of Cancer Research, London, UK. Electronic address:

Background: Ossifying fibromyxoid tumour is a rare mesenchymal soft tissue sarcoma with uncertain differentiation and variable metastatic potential.

Patients And Methods: This study offers a retrospective analysis of 23 patients diagnosed with OFMT between 1993 and 2024.

Results: The tumours most commonly arose in the extremities and trunk, with all patients undergoing surgical resection of the primary tumour.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!